Editorial
Immunocompromised Host (Especially HIV-Positive) The Target of Pyomyositis in Temperate Regions
Abstract
Pyomyositis is an acute endemic infection, initially seen in tropical areas. Over the last several years, however, more cases have been reported in temperate areas, especially among patients with immunodeficiency. This increase could reflect the use of more advanced imaging techniques, but also corresponds to a rising number of immunocompromised patients. In these patients, the incidence of pyomyositis is relatively low, at 1.5 to 3.5 cases per thousand patient years.1,2 Less frequently, pyomyositis occurs in patients with diabetes mellitus, rheumatoid arthritis, malignancy, intravenous drug use, hemophilia, and in conjunction with central venous catheter use.3,4 IV drug use and muscle injury due to trauma or exercise are recognized risk factors in HIV-positive patients.5This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.